An interventional study of Cognitive Bias Modification and Sham Training in Alcohol Drinking, sponsored by Boston University Charles River Campus. Terminated at 1 site in United States. Open to participants aged 18 Years to 34 Years. Per ClinicalTrials.gov, last updated 2026-10-02.
Sponsored by Boston University Charles River Campus · Not applicable, Interventional, and Treatment
Study terminated early due to COVID -19 and subsequent inability to run subjects at the facility.
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study seeks to better understand mechanisms of behavior change for heavy drinkers who are interested in changing their drinking. The study will examine the effects of CBM as an adjunctive treatment on neurocognitive processes related to alcohol use in a sample of heavy/at-risk drinkers using functional magnetic resonance imaging (fMRI). The primary aim of this project is to examine the effects of CBM on neurocognitive approach tendencies and control processes, among heavy/at-risk drinkers interested in changing their alcohol use. As a secondary aim, this project will investigate associations between neural and cognitive changes and changes in alcohol use to better understand how CBM might lead to successful changes in drinking behavior. Either CBM (treatment group) or sham computer task (control group) will be paired with a motivational web-based intervention for alcohol use. Brain activity will be measures twice via fMRI--pre-treatment and 1-week post-treatment. The experimental tasks completed in the fMRI scans include 2 alcohol cue reactivity (CR) tasks--one standard and one in which participants are told to either inhibit (INHIBIT) or engage in (INDULGE) their reaction to images of alcohol and neutral beverages. Follow-up drinking behavior will be measured also at 1-week and online via 1- and 6-month follow-ups. Brain activity at baseline and follow-up will be measured in pre-defined regions of interest including amygdala, NAcc, mPFC, and dlPFC. It is hypothesized that the CBM group will exhibit changes in approach biases as exhibited by reductions in brain activity in the amygdala, NAcc, mPFC in response to alcohol cues in both CR tasks (alcohol CR, INDULGE CR, and INHIBIT CR) compared to sham. In addition, those in the CBM group will show increased dlPFC brain activity during alcohol CR and INHIBIT trials of the cued-CR task as evidence strengthened control abilities in response to alcohol cues. Finally, as a secondary hypothesis, those in the CBM group will show greater reductions in drinking and craving at follow-up.
Forty heavy/at-risk drinkers (ages 18-34) who report an interest in changing their drinking behavior will be recruited for this proposed project. "Interest" will be operationalized as an affirmative answer on an item adapted (for past-month) from the CAGE questionnaire: "In the past month, have you felt you should cut down or stop drinking?" (Mayfield, McLeod, \& Hall, 1974). Heavy/at-risk drinking will be defined in terms of consumption (7+/14+ drinks per week and/or 3+/4+ drinks on one occasion over the past week for women and men, respectively; USDHHS, 2005) and score on the Alcohol Use Disorders Identification Test (AUDIT score of 8-19; Babor, Higgins-Biddle, Saunders, \& Monteiro, 2001). A score between 8-19 on the AUDIT is indicative of heavy use while scores 20 and above are indicative of a more severe alcohol use disorder (i.e., "dependence", DSM-IV; APA, 2013; APA, 2000). Participants will be recruited through online advertisements on Craigslist, social media websites, and "Quickie Job Board" listings on student websites as well as via flyers in community and student health centers. Upon responding to advertisements participants will be administered a phone screen or complete online screening survey to determine study eligibility.
If eligible, baseline assessments will be administered at an in person appointment, including self-report assessments about alcohol use, drug use, consequences, and alcohol craving. Participants will complete a baseline fMRI scan, which involves administration of two versions of an alcohol cue reactivity (CR) task. Both CR tasks administered in the scanner will consist of a block design. The first alcohol CR task consists of two types of blocks-1) alcohol and 2) neutral beverage (i.e., soft drinks, juice, water). Subjects will be presented with 40 alcohol images and 40 neutral beverage images, respectively. The second task, the cued-CR task, involves 3 blocks utilizing the same images as the alcohol-CR task. Subjects will receive instructions regarding their reaction to the photos-1) INHIBIT CR (alcohol images), 2) INHIBIT NEUTRAL (neutral beverage images), and 3) INDULGE CR (alcohol images). More specifically, participants will be given the instruction to imagine each image is available to them and to either inhibit their natural reaction to the images presented (alcohol in one block, neutral beverages in another block) or think about the possibility of consuming, in this moment, each (alcohol-containing) beverage shown. This task was inspired by fMRI studies using CR tasks and cognitive restraint strategies to inhibit cravings for food and/or alcohol (Naqvi et al., 2015; Yokum \& Stice, 2013). For both tasks, each image will be presented for 4 seconds followed by a 2 second inter-image interval. Participants will be asked to rate their level of craving after each block for the first task only. Following this baseline scan, participants will complete a brief web-based intervention for alcohol use, Rethinking Drinking: Alcohol and Your Health (NIAAA, 2015), and will subsequently be randomized to either cognitive bias modification (CBM) or sham training. They will complete the first session of either CBM or sham training after randomization as well as an additional 4 CBM/sham sessions at home (via web) over one week following baseline. Participants will return to the lab one-week following their baseline appointment. At follow-up assessment, participants will complete all baseline assessment measures in addition to a second fMRI session consisting of the same CR tasks. Finally, participants will be emailed a link to a web-based survey at 1- and 6-months following baseline to assess drinking behavior. Data analysis will employ region of interest (ROI) analysis. Predefined ROIs include the bilateral amygdala, nucleus accumbens (NAcc), and dorsolateral and medial prefrontal cortex (dlPFC and mPFC). Anatomical ROIs will be generated using the Wake Forest University (WFU) Pickatlas automatic anatomical labeling tool (Maldjian, Laurienti, Kraft, \& Burdette, 2003) available for SPM. The analytic plan for testing study hypotheses are as follows: Primary Aim 1-For the alcohol CR task, two within subject contrasts will be calculated-1] alcohol CR > neutral CR pre-CBM/sham and 2] (alcohol CR > neutral CR) pre-CBM/sham - (alcohol CR > neutral CR) post-CBM/sham-in pre-defined ROIs. Primary Aim 2-as with the alcohol CR task, the within subject contrasts will be 1] INDULGE CR > INHIBIT CR pre-CBM/sham and 2] (INDULGE CR > INHIBIT CR) pre-CBM/sham - (INDULGE CR > INHIBIT CR) post-CBM/sham. Similar within subject contrasts will be explored for INHIBIT CR and INHIBIT NEUTRAL CR as a control. T-tests will be used to compare within subject contrasts for each task as well as to compare between-group contrasts (i.e., alcohol CR and INHIBIT CR pre-and post- CBM/sham). Secondary Aim: Correlations will be run to determine whether BL BOLD activity in each ROI significantly correlate with behavioral measures for both BL and 1-week follow-up. For significant correlations, pre- and post-CBM/sham difference scores will be calculated for behavioral measures and then correlated with significant BOLD contrasts representing change in neural activity.
703 studies on the registry are indexed under Alcohol Drinking; 132 are open to participants now.
This study's enrollment of 10 is below the median of 125 across 609 interventional studies indexed under Alcohol Drinking.
Browse Alcohol Drinking studies →Boston University Charles River Campus is the lead sponsor of 160 studies on the registry; 34 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 11 (79%) have results posted.
Compared within Alcohol Drinking, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This group will receive Cognitive Bias Modification training
Behavioral: Cognitive Bias Modification
This group will receive Sham (control) training
Behavioral: Sham Training
CBM sessions are computer tasks that take 15 minutes each. CBM is similar to an alcohol approach avoidance task (AAT) in that they will involve moving their mouse forward to simulate an avoidance/push response and backward to simulate an approach/pull response in response to alcohol and neutral stimuli depending on photograph orientation. Photos will get larger as if coming toward the participant when "pulled" and will get smaller as if moving away when "pushed". CBM will involve pushing 90% of alcohol stimuli (pulling 10%) and pulling 90% of neutral stimuli (pushing 10%).
Sham training sessions are computer tasks that take 15 minutes each. Sham training is similar to an alcohol approach avoidance task (AAT) in that they will involve moving their mouse forward to simulate an avoidance/push response and backward to simulate an approach/pull response in response to alcohol and neutral stimuli depending on photograph orientation. Photos will get larger as if coming toward the participant when "pulled" and will get smaller as if moving away when "pushed". Sham training will involve pushing and pulling 50% of each type of stimuli (alcohol and neutral)
Blood Oxygen Level Dependent (BOLD) Signal Change
Blood oxygen level dependent (BOLD) signal change in ROIs \[amygdala, nucleus accumbent (NAcc), medial prefrontal cortex (mPFC), dorsolateral prefrontal cortex (dlPFC) during alcohol cue-reactivity decreased signal indicates better outcomes for amygdala, NAcc, and mPFC; increased signal indicates better outcomes for dlPFC
Time frame: 1-week
BOLD Signal Change in ROIs (Amygdala, NAcc, mPFC, dlPFC) During INHIBIT Cue-reactivity
Decreased signal indicates better outcomes for amygdala, NAcc, and mPFC; increased signal indicates better outcomes for dlPFC
Time frame: 1-week
BOLD Signal Change in ROIs (Amygdala, NAcc, mPFC) During INDULGE Cue-reactivity
Decreased BOLD signal change in ROIs indicates better outcomes for amygdala, NAcc, and mPFC
Time frame: 1-week
Drinking Behavior
Daily Drinking Questionnaire quantity item "most drinks on one occasion"; range 0-31; higher score = more drinking/worse outcome
Time frame: 1-week
Drinking Behavior
Daily Drinking Questionnaire quantity item "most drinks on one occasion"; range 0-31; higher score = more drinking/worse outcome
Time frame: 1-month
Drinking Behavior
Daily Drinking Questionnaire quantity item "most drinks on one occasion"; range 0-31; higher score = more drinking/worse outcome
Time frame: 6-months
Alcohol Craving
Score on Desire for Alcohol Questionnaire; range (average of all 14 items) = -3 - 3; higher scores reflect higher desire for alcohol (worse outcome)
Time frame: 1-week
Alcohol Craving
Score on Desire for Alcohol Questionnaire; range (average of all 14 items) = -3 - 3; ; higher scores reflect higher desire for alcohol (worse outcome)
Time frame: 1-month
Individuals were recruited for this study via student job board postings, Facebook advertisements, and advertisements in student health clinics. Recruitment spanned from 8/21/2019 to 2/25/2020. Recruitment and enrollment were halted as of 3/17/2020 due to COVID-19 and associated shutting down of universities and research space.
| Milestone | CBM Group | Control Group |
|---|---|---|
| Started | 4 | 4 |
| Completed | 0 | 0 |
| Not completed | 4 | 4 |
| Withdrew: Study discontinued due to covid-19 | 4 | 4 |
Blood oxygen level dependent (BOLD) signal change in ROIs \[amygdala, nucleus accumbent (NAcc), medial prefrontal cortex (mPFC), dorsolateral prefrontal cortex (dlPFC) during alcohol cue-reactivity decreased signal indicates better outcomes for amygdala, NAcc, and mPFC; increased signal indicates better outcomes for dlPFC
No measurements were reported for this outcome.
Decreased signal indicates better outcomes for amygdala, NAcc, and mPFC; increased signal indicates better outcomes for dlPFC
No measurements were reported for this outcome.
Decreased BOLD signal change in ROIs indicates better outcomes for amygdala, NAcc, and mPFC
No measurements were reported for this outcome.
Daily Drinking Questionnaire quantity item "most drinks on one occasion"; range 0-31; higher score = more drinking/worse outcome
| drinks/occassion | CBM Group | Control Group |
|---|---|---|
| Drinking Behavior | 8.67 ± 4.04 | 6.25 ± 1.71 |
Daily Drinking Questionnaire quantity item "most drinks on one occasion"; range 0-31; higher score = more drinking/worse outcome
| drinks/occassion | CBM Group | Control Group |
|---|---|---|
| Drinking Behavior | — | 6.25 ± 2.06 |
Daily Drinking Questionnaire quantity item "most drinks on one occasion"; range 0-31; higher score = more drinking/worse outcome
No measurements were reported for this outcome.
Score on Desire for Alcohol Questionnaire; range (average of all 14 items) = -3 - 3; higher scores reflect higher desire for alcohol (worse outcome)
| score on a scale | CBM Group | Control Group |
|---|---|---|
| Alcohol Craving | -1.60 ± .27 | -1.73 ± .39 |
Score on Desire for Alcohol Questionnaire; range (average of all 14 items) = -3 - 3; ; higher scores reflect higher desire for alcohol (worse outcome)
| score on a scale | CBM Group | Control Group |
|---|---|---|
| Alcohol Craving | — | -1.55 ± .56 |
Collected over Adverse event data were collected over the course of 6 months for each participant.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| CBM Group | 0/4 (0%) | 0/4 (0%) | 0/4 (0%) |
| Control Group | 0/4 (0%) | 0/4 (0%) | 0/4 (0%) |
| Age, Continuous(years) | CBM Group | Control Group | Total |
|---|---|---|---|
| Mean | 22.75 ± 3.30 | 22.0 ± 5.48 | 22.38 ± 3.06 |
| Sex: Female, Male(Participants) | CBM Group | Control Group | Total |
|---|---|---|---|
| Female | 0 | 2 | 2 |
| Male | 4 | 2 | 6 |
| Race and Ethnicity Not Collected(Participants) | CBM Group | Control Group | Total |
|---|---|---|---|
| Count of participants | — | — | 0 |
| past month frequency of drinking(days/month) | CBM Group | Control Group | Total |
|---|---|---|---|
| Mean | 3.75 ± .5 | 3 ± 0 | 3.38 ± .52 |
| Weekend drinking quantity(drinks/day) | CBM Group | Control Group | Total |
|---|---|---|---|
| Mean | 5 ± 1.63 | 4.25 ± .5 | 4.63 ± 1.19 |
| Greatest number of drinks consumed(drinks/occassion) | CBM Group | Control Group | Total |
|---|---|---|---|
| Mean | 9 ± 4.24 | 7.25 ± 1.71 | 8.13 ± 3.14 |
| Alcohol Craving(score on scale) | CBM Group | Control Group | Total |
|---|---|---|---|
| Mean | -2.0 ± .27 | -1.38 ± .24 | -1.69 ± .41 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Aug 2019 to primary completion in Aug 2021, 24 months.
Results were first posted in Oct 2026, 5 years 1 month after primary completion.
How these figures are worked out, and which studies are left out of them.
Study terminated early due to COVID -19 and subsequent inability to run subjects at the facility.
Study terminated early due to COVID -19 and subsequent inability to run subjects at the facility.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is terminated, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Boston University Charles River Campus →